Back to news

Why Charles River Laboratories (CRL) Stock Is Up Today

Investivoq PriceTracker

Charles River Laboratories (CRL) is up 4.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued bullish follow-through from the company’s late-September investor day, where management reaffirmed 2026 guidance and outlined stronger long-term growth and margin targets. With third-quarter results scheduled for November 4, investors also appear to be positioning for another update after several recent strategic and digital-execution announcements.

Details:

  • At its September 24 investor day, Charles River said it expects 2026 revenue and non-GAAP EPS to land at the upper ends of prior guidance ranges.
  • The company also introduced 2030 targets that call for 5% to 7% organic revenue growth, about 24% non-GAAP operating margin, and low-double-digit non-GAAP EPS growth.
  • On October 6, Charles River announced a new Apollo Orchestrate capability with Autolomous, extending its push into digitized laboratory workflows and greater client transparency.
  • Charles River said on October 9 that it will report third-quarter 2026 results before the market opens on November 4, giving traders a near-term catalyst as the stock continues its strong 2026 run.

    • Sources:

    Charles River Laboratories Investor Relations, SEC, Yahoo Finance

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $CRL Insider Trading Activity

    CRL Insider Trades

    $CRL insiders have traded $CRL stock on the open market 20 times in the past 6 months. Of those trades, 1 have been purchases and 19 have been sales.

    Here’s a breakdown of recent trading of $CRL stock by insiders over the last 6 months:

    • JAMES C FOSTER has made 0 purchases and 3 sales selling 137,294 shares for an estimated $34,844,875.
    • SHANNON M PARISOTTO (CEVP, Disc & Safety Assessment) has made 0 purchases and 4 sales selling 11,780 shares for an estimated $3,268,045.
    • BIRGIT GIRSHICK (Chief Executive Officer) sold 6,500 shares for an estimated $1,819,349
    • MICHAEL GUNNAR KNELL (SVP, Finance and CAO) has made 0 purchases and 9 sales selling 6,645 shares for an estimated $1,730,249.
    • VICTORIA L CREAMER (EVP & Chief People Officer) sold 4,179 shares for an estimated $1,083,029
    • NANCY C ANDREWS sold 573 shares for an estimated $163,442
    • GLENN COLEMAN (EVP & Chief Financial Officer) purchased 10 shares for an estimated $2,974

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    EARLY ACCESS
    Receive CRL Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $CRL Hedge Fund Activity

    We have seen 258 institutional investors add shares of $CRL stock to their portfolio, and 262 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • FMR LLC added 783,508 shares (+22.7%) to their portfolio in Q2 2026, for an estimated $177,691,779
    • MACKENZIE FINANCIAL CORP removed 593,254 shares (-99.7%) from their portfolio in Q2 2026, for an estimated $134,544,074
    • INVESCO LTD. added 587,533 shares (+24.5%) to their portfolio in Q2 2026, for an estimated $133,246,609
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 467,663 shares (+inf%) to their portfolio in Q2 2026, for an estimated $106,061,291
    • ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 458,472 shares (-62.2%) from their portfolio in Q2 2026, for an estimated $103,976,864
    • MILLENNIUM MANAGEMENT LLC removed 447,583 shares (-47.9%) from their portfolio in Q2 2026, for an estimated $101,507,348
    • D. E. SHAW & CO., INC. removed 399,541 shares (-92.7%) from their portfolio in Q2 2026, for an estimated $90,611,903

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $CRL Price Targets

    Multiple analysts have issued price targets for $CRL recently. We have seen 4 analysts offer price targets for $CRL in the last 6 months, with a median target of $220.0.

    Here are some recent targets:

    • Ricky Goldwasser from Morgan Stanley set a target price of $260.0 on 07/09/2026
    • Michael Luo from CLSA set a target price of $219.0 on 05/29/2026
    • Ross Muken from Evercore ISI Group set a target price of $220.0 on 05/08/2026
    • Luke Sergott from Barclays set a target price of $220.0 on 05/08/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.